Issue 1 2007

Download Print Send a summary of this page to someone via email.

Featuring


Cancer immunotherapy using RNAi
Dr Wu, et al, John Hopkins Medical Institutions discusses their research into cancer immunotherapy using RNAi technology

A new field in biomarker discovery and target identification
Dr. Ina Dahlsveen, Exiqon informs us about a new field in biomarker discovery and target identification

The role of phospho-proteomics in drug discovery and development
Ze'ev Gechtman, Ph.D., formerly of Johnson & Johnson

HCS roundtable; Achieving the potential of HCS
Read what the technology users and vendors have to say about the future of HCS

High throughput electrophysiology platforms as enablers
Peter Haddock, Ph.D., Pfizer Global Research & Development, CNS Pharmacology examines the significant advances in electrophysiology screening

New opportunities for protein crystallization
Automated Matrix Seeding: new opportunities for protein crystallisation
Allan D'Arcy, Novartis Institutes of Biomedical Research, Protease Platform, Switzerland 

Real-time PCR gene expression profiling
Mikael Kubista, TATAA Biocenter and MultiD Analyses AB, Sweden

PAT for freeze drying: cycle optimization in the laboratory
Dr. Henning Gielseler, PhD., Department of Pharmaceutics, University of Erlangen-Nuremberg discusses the role of Process Analytical Technology for freeze drying

IFPAC 2007 Preview

PAT for the product lifecycle of a biopharmaceutical product
Process Analytical Technology for the product lifecycle of a biopharmaceutical product
Ronan O'Kennedy, Biopharmaceutical Process Development, Biopharmaceutical CEDD, GlaxosmithKline

Are the needs of the pharmaceutical industry being met?
Dr Andrew M.Middleton, GlaxosmithKline explains

If you wish to view the magazine in PDF format (size: 2.01 MB), please click HERE